Comprehensive genomic profile of heterogeneous long follow-up triple-negative breast cancer and its clinical characteristics shows DNA repair deficiency has better prognostic
Triple-negative breast cancer (TNBC) presents a marked diversity at the molecular level, which promotes a clinical heterogeneity that further complicates treatment. We performed a detailed whole exome sequencing profile of 29 Mexican patients with long follow-up TNBC to identify genomic alterations...
- Autores:
-
Rojas-Jiménez, Ernesto
Mejía-Gómez, Javier César
Díaz-Velásquez, Clara Estela
Quezada-Urbán, Rosalía
Gregorio, Héctor Martínez
Vallejo Lecuona, Fernando
De La Cruz Montoya, Aldo Hugo
Reyes, Fany Iris Porras
Pérez-Sánchez, Víctor Manuel
Maldonado-Martinez, Hector Aquiles
Robles-Estrada, Maybelline
Bargalló-Rocha, Enrique
Cabrera-Galeana, Paula
Ramos-Ramírez, Maritza
Chirino, Yolanda I
Herrera, Luis Alonso
Terrazas, Luis I.
Oliver, Javier
Frecha, Cecilia A.
Perdomo Lara, Sandra Janneth
Vaca Paniagua, Felipe
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad El Bosque
- Repositorio:
- Repositorio U. El Bosque
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.unbosque.edu.co:20.500.12495/5187
- Palabra clave:
- Triple-negative breast cancer
Whole exome sequencing
WES
Treatment
Somatic mutation
Mutational signatures
- Rights
- openAccess
- License
- Attribution 4.0 International
Summary: | Triple-negative breast cancer (TNBC) presents a marked diversity at the molecular level, which promotes a clinical heterogeneity that further complicates treatment. We performed a detailed whole exome sequencing profile of 29 Mexican patients with long follow-up TNBC to identify genomic alterations associated with overall survival (OS), disease-free survival (DFS), and pathologic complete response (PCR), with the aim to define their role as molecular predictive factors of treatment response and prognosis. We detected 31 driver genes with pathogenic mutations in TP53 (53%), BRCA1/2 (27%), CDKN1B (9%), PIK3CA (9%), and PTEN (9%), and 16 operative mutational signatures. Moreover, tumors with mutations in BRCA1/2 showed a trend of sensitivity to platinum salts. We found an association between deficiency in DNA repair and surveillance genes and DFS. Across all analyzed tumors we consistently found a heterogeneous molecular complexity in terms of allelic composition and operative mutational processes, which hampered the definition of molecular traits with clinical utility. This work contributes to the elucidation of the global molecular alterations of TNBC by providing accurate genomic data that may help forthcoming studies to improve treatment and survival. This is the first study that integrates genomic alterations with a long follow-up of clinical variables in a Latin American population that is an underrepresented ethnicity in most of the genomic studies. |
---|